Yahoo
    Swiss - Delayed Quote CHF

    Santhera Pharmaceuticals Holding AG (SANN.SW)

    14.92 +0.26 (+1.77%)
    At close: November 6 at 5:30:15 PM GMT+1
    Loading Chart for SANN.SW
    Chart Range Bar
    Interval:
    In partnership with ChartIQ

    Recent News

    Santhera Pharmaceuticals CFO on AGAMREE growth in 2026 - One2One Investor Forum

    Santhera Pharmaceuticals CFO on AGAMREE growth in 2026 - One2One Investor Forum
    Proactive 4d ago
    Santhera reports 101% revenue growth as AGAMREE expands across global markets

    Santhera reports 101% revenue growth as AGAMREE expands across global markets
    Proactive 1mo ago
    Santhera nears cash break-even as AGAMREE gains traction, Edison says

    Santhera nears cash break-even as AGAMREE gains traction, Edison says
    Proactive 2mo ago
    Santhera Expands Biomedica Agreement to Extend AGAMREE® (Vamorolone) Distribution Across Central Asia and the Caucasus

    Santhera Expands Biomedica Agreement to Extend AGAMREE® (Vamorolone) Distribution Across Central Asia and the Caucasus
    GlobeNewswire 3mo ago
    Santhera Announces Orphan Drug and Priority Review Designations for AGAMREE® (Vamorolone) in South Korea

    Santhera Announces Orphan Drug and Priority Review Designations for AGAMREE® (Vamorolone) in South Korea
    GlobeNewswire 5mo ago
    Santhera’s Shareholders Approve all Board Proposals at Today’s Annual General Meeting

    Santhera’s Shareholders Approve all Board Proposals at Today’s Annual General Meeting
    GlobeNewswire 5mo ago
    Santhera Publishes Agenda for its Annual General Meeting

    Santhera Publishes Agenda for its Annual General Meeting
    GlobeNewswire 6mo ago
    Santhera Pharmaceuticals, AOTI, Poolbeg Pharma, Solvonis Therapeutics, IBT

    Santhera Pharmaceuticals, AOTI, Poolbeg Pharma, Solvonis Therapeutics, IBT
    Proactive 6mo ago
    Santhera Proposes Dr. Srishti Gupta as New Member of the Board of Directors

    Santhera Proposes Dr. Srishti Gupta as New Member of the Board of Directors
    GlobeNewswire 6mo ago
    Santhera Pharmaceuticals Holding AG (SPHDF) Full Year 2025 Earnings Call Highlights: Revenue ...

    Santhera Pharmaceuticals Holding AG (SPHDF) Full Year 2025 Earnings Call Highlights: Revenue ...
    GuruFocus.com 6mo ago
    Santhera Pharmaceuticals CFO on strong FY25 performance & AGAMREE expansion

    Santhera Pharmaceuticals CFO on strong FY25 performance & AGAMREE expansion
    Proactive 6mo ago

    Related Tickers

    Mobilize your Website
    View Site in Mobile | Classic
    Share by: